cgtafrica
CTG Africa
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been establishedby the African Institute
To enhance Africa’s capacity for drug discovery, development & deployment and to harness the power of genomics for improved health in Africa.
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been established by the African Institute of Biomedical Science and Technology (AiBST) as a mechanism to implement its Bill and Melinda Gates (BMGF) Calestous Juma (CJ) Research Leadership award to Prof. Collen Masimirembwa.
The two main aims of the award being to establish a drug discovery ecosystem and to expand pharmacogenomic testing for improved health in Africa
To enhance Africa’s capacity for drug discovery, development & deployment and to harness the power of genomics
Establishing advanced technology platforms and training highly skilled scientists & expand the clinical
To build capacity for bioanalytics, genomics, bioinformatics and pharmacometrics to support translational science
To harness Africa’s genomic diversity in health research and innovation for drugs, vaccines, diagnostics and medical devices.
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been establishedby the African Institute
To enhance Africa’s capacity for drug discovery, development & deployment and toharness the power of
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been establishedby the African Institute
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been established
by the African Institute of Biomedical Science and Technology (AiBST)
Get The Latest Updates via email. Any time you may unsubscribe
